IceCure Medical Ltd (ICCM) Stock Analysis & Investment Frameworks
IceCure Medical Ltd (ICCM) stock analysis on Invetso. Review IceCure Medical Ltd’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
IceCure Medical Ltd Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: IL
IceCure Medical Ltd Key Financial Metrics
- Market Cap: $1.74M
- Revenue: $3.38M
- ROE: -174.26%
- ROIC: -183.21%
- Dividend Yield: N/A
About IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
IceCure Medical Ltd Investment Frameworks
Invetso analyzes IceCure Medical Ltd (ICCM) across the following frameworks:
- IceCure Medical Ltd 10Y Growth Potential
- IceCure Medical Ltd Scenario Analysis
- IceCure Medical Ltd Risks & Opportunities
- IceCure Medical Ltd Economic Moat
- IceCure Medical Ltd Business Model
- IceCure Medical Ltd Management
- IceCure Medical Ltd SWOT Analysis
- IceCure Medical Ltd Porter's 5 Forces
- IceCure Medical Ltd PESTLE Analysis
- IceCure Medical Ltd ESG Analysis